An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
Clinical trial NCT03769168 · COMPLETED
Trial details
- NCT number
- NCT03769168
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-07
- Primary completion
- 2024-11-07
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.